Codexis Inc (CDXS)
2.65
-0.15
(-5.36%)
USD |
NASDAQ |
Apr 25, 16:00
2.66
+0.01
(+0.38%)
After-Hours: 20:00
Codexis Profit Margin (Quarterly): -27.08% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -27.08% |
September 30, 2023 | -376.3% |
June 30, 2023 | -54.04% |
March 31, 2023 | -174.2% |
December 31, 2022 | -41.49% |
September 30, 2022 | -28.99% |
June 30, 2022 | -6.87% |
March 31, 2022 | -23.64% |
December 31, 2021 | -41.59% |
September 30, 2021 | 6.10% |
June 30, 2021 | -16.76% |
March 31, 2021 | -50.29% |
December 31, 2020 | -18.64% |
September 30, 2020 | -33.15% |
June 30, 2020 | -42.39% |
March 31, 2020 | -52.16% |
December 31, 2019 | -3.40% |
September 30, 2019 | 1.57% |
June 30, 2019 | -52.82% |
March 31, 2019 | -32.96% |
December 31, 2018 | -2.87% |
September 30, 2018 | -11.73% |
June 30, 2018 | -27.59% |
March 31, 2018 | -33.43% |
December 31, 2017 | 4.47% |
Date | Value |
---|---|
September 30, 2017 | -102.4% |
June 30, 2017 | -60.69% |
March 31, 2017 | -93.59% |
December 31, 2016 | -52.76% |
September 30, 2016 | 9.66% |
June 30, 2016 | 13.99% |
March 31, 2016 | -87.22% |
December 31, 2015 | -17.72% |
September 30, 2015 | 31.00% |
June 30, 2015 | -89.07% |
March 31, 2015 | -81.82% |
December 31, 2014 | 2.43% |
September 30, 2014 | -61.05% |
June 30, 2014 | -129.1% |
March 31, 2014 | -90.12% |
December 31, 2013 | -103.0% |
September 30, 2013 | -234.9% |
June 30, 2013 | -180.7% |
March 31, 2013 | -83.82% |
December 31, 2012 | -196.4% |
September 30, 2012 | -8.77% |
June 30, 2012 | -24.09% |
March 31, 2012 | -24.06% |
December 31, 2011 | -15.81% |
September 30, 2011 | -8.24% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-376.3%
Minimum
Sep 2023
6.10%
Maximum
Sep 2021
-54.53%
Average
-33.15%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
Sutro Biopharma Inc | 27.32% |
Avidity Biosciences Inc | -2.76K% |
Taysha Gene Therapies Inc | -- |
Janux Therapeutics Inc | -477.8% |
Tango Therapeutics Inc | -566.4% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -66.52% |
Return on Assets | -39.45% |
Return on Invested Capital | -66.52% |
Gross Profit Margin (Quarterly) | 89.22% |
Operating Margin (Quarterly) | 1.06% |
Return on Net Operating Assets | -83.29% |